Satellos Bioscience Inc. (MSLE) stock
MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 27, 2026Score 5/30
$6.20−0.27 (-4.17%)
Close on Nov 17, 2026Market cap $95.85MP/E –Yield –
Satellos Bioscience r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $18.43M, up 28.3% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.43M | +28.3% |
| FY2024 | Dec 31, 2024 | $14.36M | – |
See a number that looks wrong?